Cyprus · Delayed Price · Currency is EUR CYS:CLL Statistics
Total Valuation
CYS:CLL has a market cap or net worth of EUR 1.15 million. The enterprise value is -380,587.
| Market Cap | 1.15M |
| Enterprise Value | -380,587 |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CYS:CLL has 288.14 million shares outstanding.
| Current Share Class | 288.14M |
| Shares Outstanding | 288.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 182.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.61 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.05, with a Debt / Equity ratio of 0.13.
| Current Ratio | 14.05 |
| Quick Ratio | 13.95 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -19.79 |
| Interest Coverage | -1.09 |
Financial Efficiency
Return on equity (ROE) is -2.73% and return on invested capital (ROIC) is -0.91%.
| Return on Equity (ROE) | -2.73% |
| Return on Assets (ROA) | -0.31% |
| Return on Invested Capital (ROIC) | -0.91% |
| Return on Capital Employed (ROCE) | -0.52% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CYS:CLL has paid 9,225 in taxes.
| Income Tax | 9,225 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.11% in the last 52 weeks. The beta is 0.58, so CYS:CLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -11.11% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 45.52 |
| Average Volume (20 Days) | 35,486 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CYS:CLL had revenue of EUR 133,897 and -116,610 in losses. Loss per share was -0.00.
| Revenue | 133,897 |
| Gross Profit | 133,897 |
| Operating Income | -24,337 |
| Pretax Income | -107,385 |
| Net Income | -116,610 |
| EBITDA | -24,087 |
| EBIT | -24,337 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2.07 million in cash and 539,948 in debt, with a net cash position of 1.53 million or 0.01 per share.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 539,948 |
| Net Cash | 1.53M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 4.21M |
| Book Value Per Share | 0.01 |
| Working Capital | 1.95M |
Cash Flow
| Operating Cash Flow | -27,288 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 250 |
| Net Borrowing | -64,961 |
| Free Cash Flow | -27,288 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -18.18% and -87.09%.
| Gross Margin | 100.00% |
| Operating Margin | -18.18% |
| Pretax Margin | -80.20% |
| Profit Margin | -87.09% |
| EBITDA Margin | -17.99% |
| EBIT Margin | -18.18% |
| FCF Margin | n/a |
Dividends & Yields
CYS:CLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.12% |
| FCF Yield | -2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CYS:CLL has an Altman Z-Score of 0.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 2 |